
至 2028 年亚太地区电生理学市场预测 – COVID-19 影响和区域分析 – 按产品(电生理学消融导管、电生理学实验室设备、电生理学诊断导管、接入设备等)和适应症 [心房颤动 (AF) 、心房扑动、沃尔夫-帕金森怀特综合征 (WPW)、房室结折返性心动过速 (AVNRT) 等]
No. of Pages: 142 | Report Code: BMIRE00026175 | Category: Life Sciences
No. of Pages: 142 | Report Code: BMIRE00026175 | Category: Life Sciences
亚太地区电生理学市场预计将从 2022 年的20.7072 亿美元增长到美元到 2028 年将超过 3,802.83 百万;预计2022年至2028年复合年增长率为10.7%。
引进技术先进的电生理设备是影响该地区电生理学市场增长的重要因素之一。支持改进心律监测的各种先进测绘和引导系统的使用预计将在预测期内增加这些设备的使用率。 GE Healthcare 的 Innova IGS 520 和 Optima IGS 320 等技术创新预计将为市场参与者提供利润丰厚的增长机会。这些产品是剂量高效的介入 X 射线系统,使医生能够高效、准确地执行复杂的介入手术。此外,市场参与者还为医疗保健行业提供技术先进的解决方案、新产品和批准。例如,2019 年 1 月,雅培推出了用于治疗心房颤动的传感器驱动的 TachiCath 接触力消融导管,该导管能够在消融过程中对心脏进行准确成像。此外,2019 年 9 月,强生公司 (Johnson & Johnson (Biosense Webster) 推出了 CARTONET,这是世界上第一个基于云的安全网络,供电生理学家审查、分析和共享心房颤动病例数据,以提高手术效率。 2022 年 1 月,制药公司雅培实验室 (Abbott Laboratories) 获得 FDA 批准,可以使用采用全极 EnSite 技术的 EnSite X 电生理系统来治疗心房颤动患者。
p>
因此,心房颤动 (AF) 患病率的上升、技术先进解决方案的引入以及产品的发布和批准预计将在预测期内推动亚太地区电生理学市场的发展。< /p>
借助新功能和技术,供应商可以吸引新客户并扩大其在新兴市场的足迹。这一因素可能会在预测期内推动亚太地区电生理学市场实现大幅复合年增长率。
亚太地区电生理学市场细分
亚太地区电生理学市场根据产品、适应症和国家/地区进行细分。根据产品,市场分为电生理消融导管、电生理实验室设备、电生理诊断导管、接入设备等。电生理实验室设备细分市场将在 2022 年占据市场主导地位,电生理消融导管细分市场预计将在预测期内增长最快。根据适应症,市场分为心房颤动(AF)、心房扑动、房室结折返性心动过速(AVNRT)、沃尔夫-帕金森-怀特综合征(WPW)等。心房颤动 (AF) 领域在 2022 年占据市场主导地位,预计在预测期内增长最快。按国家/地区划分,亚太地区电生理学市场分为中国、印度、日本、澳大利亚、韩国和亚太地区其他地区。
雅培;百多力公司;波士顿科学公司;心脏焦点;通用电气医疗保健;强生公司约翰逊服务公司;皇家飞利浦公司;美敦力;微创科学公司;和西门子 Healthineers AG 是亚太地区电生理学市场的领先公司之一。
Strategic insights for Asia-Pacific Electrophysiology involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2022 | US$ 2,070.72 Million |
Market Size by 2028 | US$ 3,802.83 Million |
Global CAGR (2022 - 2028) | 10.7% |
Historical Data | 2020-2021 |
Forecast period | 2023-2028 |
Segments Covered |
By 产品
|
Regions and Countries Covered | 亚太地区
|
Market leaders and key company profiles |
The regional scope of Asia-Pacific Electrophysiology refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Asia-Pacific Electrophysiology Market is valued at US$ 2,070.72 Million in 2022, it is projected to reach US$ 3,802.83 Million by 2028.
As per our report Asia-Pacific Electrophysiology Market, the market size is valued at US$ 2,070.72 Million in 2022, projecting it to reach US$ 3,802.83 Million by 2028. This translates to a CAGR of approximately 10.7% during the forecast period.
The Asia-Pacific Electrophysiology Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia-Pacific Electrophysiology Market report:
The Asia-Pacific Electrophysiology Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia-Pacific Electrophysiology Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia-Pacific Electrophysiology Market value chain can benefit from the information contained in a comprehensive market report.